Neuropsychiatry of the basal ganglia

This review aims to relate recent findings describing the role and neural connectivity of the basal ganglia to the clinical neuropsychiatry of basal ganglia movement disorders and to the role of basal ganglia disturbances in “psychiatric”' states. Articles relating to the relevant topics were initially collected through MEDLINE and papers relating to the clinical conditions discussed were also reviewed. The anatomy and connections of the basal ganglia indicate that these structures are important links between parts of the brain that have classically been considered to be related to emotional functioning and brain regions previously considered to have largely motor functions. The basal ganglia have a role in the development and integration of psychomotor behaviours, involving motor functions, memory and attentional mechanisms, and reward processes.

[1]  A. Tröster,et al.  Risk factors for dementia in Parkinson's disease: effect of education. , 1996, Neuroepidemiology.

[2]  S. Folstein,et al.  The association of affective disorder with Huntington's Disease in a case series and in families , 1983, Psychological Medicine.

[3]  G. Sawle,et al.  PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. , 1992, Advances in neurology.

[4]  R. Robinson,et al.  Depression in neurologic disease , 1993 .

[5]  John L Bradshaw,et al.  Frontostriatal deficits in unipolar major depression , 1998, Brain Research Bulletin.

[6]  Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. , 1999, The New England journal of medicine.

[7]  G Bernardi,et al.  Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.

[8]  K. Marder,et al.  Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. , 2001, The American journal of psychiatry.

[9]  S. Folstein,et al.  Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease , 1992, Neurology.

[10]  P. Bräunig,et al.  Prevalence of obsessive–compulsive disorder in schizophrenia and significance of motor symptoms , 2002, European Psychiatry.

[11]  R G Robinson,et al.  Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.

[12]  J. Cummings,et al.  Obsessive-compulsive disorder in Huntington's disease , 1992, Biological Psychiatry.

[13]  P. König Psychopathological alterations in cases of symmetrical basal ganglia sclerosis , 1989, Biological Psychiatry.

[14]  E. Bullmore,et al.  Society for Neuroscience Abstracts , 1997 .

[15]  A. Lees,et al.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.

[16]  R. Albin,et al.  Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome , 1999, Neurology.

[17]  H. Mayberg,et al.  Cognitive impairments and depression in Parkinson's disease: a follow up study. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[18]  Holly Moore,et al.  The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia , 1999, Biological Psychiatry.

[19]  J C Rothwell,et al.  A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. , 1998, Brain : a journal of neurology.

[20]  M. Cooper,et al.  Basal ganglia regional glucose metabolism asymmetry during a catatonic episode , 1989, Biological Psychiatry.

[21]  A J Lees,et al.  Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study. , 1987, Brain : a journal of neurology.

[22]  A. Rosenblatt,et al.  Neuropsychiatry of Huntington's disease and other basal ganglia disorders. , 2000, Psychosomatics.

[23]  M. Trimble,et al.  Electroconvulsive therapy in Parkinson's disease and other movement disorders , 1991, Movement disorders : official journal of the Movement Disorder Society.

[24]  M. Kimura,et al.  Neuronal activity in the basal ganglia. Functional implications. , 1997, Advances in neurology.

[25]  D. Joel,et al.  The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum , 2000, Neuroscience.

[26]  L. Golbe,et al.  Prevalence and natural history of progressive supranuclear palsy , 1988, Neurology.

[27]  T. Robbins,et al.  Associative Processes in Addiction and Reward The Role of Amygdala‐Ventral Striatal Subsystems , 1999, Annals of the New York Academy of Sciences.

[28]  R. Kerwin,et al.  Schizophrenia, psychosis, and the basal ganglia. , 1997, The Psychiatric clinics of North America.

[29]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[30]  K. Hugdahl,et al.  Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[31]  G. Comi,et al.  Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study , 2002, Biological Psychiatry.

[32]  Joseph B. Martin Huntington's disease , 1984, Neurology.

[33]  D. Sax,et al.  Increased rate of suicide among patients with Huntington's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[34]  C. Goetz,et al.  Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.

[35]  E. Smeraldi,et al.  Increased right caudate nucleus size in obsessive-compulsive disorder: Detection with magnetic resonance imaging , 1992, Psychiatry Research: Neuroimaging.

[36]  H. Mayberg,et al.  Depression in Parkinson's disease: a biochemical and organic viewpoint. , 1995, Advances in neurology.

[37]  B. Knowlton,et al.  Learning and memory functions of the Basal Ganglia. , 2002, Annual review of neuroscience.

[38]  M Ashtari,et al.  Reduced caudate nucleus volume in obsessive-compulsive disorder. , 1995, Archives of general psychiatry.

[39]  S. Rauch,et al.  Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. , 1997, The Psychiatric clinics of North America.

[40]  D. Senitz,et al.  Increased volume of the nucleus accumbens in schizophrenia , 2001, Journal of Neural Transmission.

[41]  S. Folstein,et al.  Huntington disease in Maryland: clinical aspects of racial variation. , 1987, American journal of human genetics.

[42]  Scott T. Grafton,et al.  Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease. , 1992, Archives of general psychiatry.

[43]  A. Tröster,et al.  Unilateral pallidal stimulation for Parkinson's disease: Neurobehavioral functioning before and 3 months after electrode implantation , 1997, Neurology.

[44]  Douglas L. Jones,et al.  From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.

[45]  C. McDougle,et al.  [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. , 1995, The American journal of psychiatry.

[46]  S. Kapur,et al.  Serotonin-dopamine interaction and its relevance to schizophrenia. , 1996, The American journal of psychiatry.

[47]  H. Allain,et al.  Depression in Parkinson's disease , 2000, BMJ : British Medical Journal.

[48]  T. Nakajima,et al.  Haplotype and mutation analysis in Japanese patients with Wilson disease. , 1997, American journal of human genetics.

[49]  J. Stessman,et al.  Cognitive disturbances in Parkinsonian patients with depression , 1993 .

[50]  Garrett E. Alexander Basal ganglia , 1998 .

[51]  T. Yen Hepadnaviral X Protein:Review of Recent Progress. , 1996, Journal of biomedical science.

[52]  J. Soares,et al.  The anatomy of mood disorders—review of structural neuroimaging studies , 1997, Biological Psychiatry.

[53]  L. Henriksen,et al.  Striatal dysfunction in attention deficit and hyperkinetic disorder. , 1989, Archives of neurology.

[54]  W. Schultz,et al.  Changes in reward‐induced brain activation in opiate addicts , 2001, The European journal of neuroscience.

[55]  H. Fibiger,et al.  Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. , 1994, The Journal of pharmacology and experimental therapeutics.

[56]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[57]  Jeste,et al.  Psychoses in Parkinson's Disease. , 1998, Seminars in clinical neuropsychiatry.

[58]  M. Nader,et al.  Progression of Changes in Dopamine Transporter Binding Site Density as a Result of Cocaine Self-Administration in Rhesus Monkeys , 2001, The Journal of Neuroscience.

[59]  K. Donaghue Autonomic Neuropathy: Diagnosis and Impact on Health in Adolescents with Diabetes , 1998, Hormone Research in Paediatrics.

[60]  The American Psychiatric Press Textbook of Geriatric Neuropsychiatry , 2000 .

[61]  B. Maccarthy,et al.  Psychiatric morbidity in patients with Parkinson's disease , 1990, Psychological Medicine.

[62]  Andreas Heinz,et al.  Tourette's syndrome , 1998, Neurology.

[63]  J. R. Baker,et al.  Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[64]  J. Cummings,et al.  Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.

[65]  Joseph Piven,et al.  An MRI study of the basal ganglia in autism , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[66]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[67]  J. Cummings,et al.  Range of neuropsychiatric disturbances in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[68]  A. Coppen Depression as a lethal disease: prevention strategies. , 1994, The Journal of clinical psychiatry.

[69]  Matthew A. Menza,et al.  Parkinson's disease and anxiety: Comorbidity with depression , 1993, Biological Psychiatry.

[70]  M. Robertson,et al.  Tic disorders: new developments in Tourette syndrome and related disorders. , 1998, Current opinion in neurology.

[71]  R. Bornstein,et al.  Depression accounts for executive function deficits in obsessive-compulsive disorder. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[72]  M. Trimble,et al.  Dopamine receptor availability in Tourette's syndrome , 1994, Psychiatry Research: Neuroimaging.

[73]  D. Joel,et al.  Open interconnected model of basal ganglia‐thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[74]  B. Bogerts,et al.  The pathomorphology of schizophrenia and mood disorders: similarities and differences , 1999, Schizophrenia Research.

[75]  T. Dening,et al.  Wilson's disease: A longitudinal study of psychiatric symptoms , 1990, Biological Psychiatry.

[76]  C. Frith,et al.  Prefrontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography , 1997, Psychological Medicine.

[77]  J. Saint-Cyr,et al.  Parkinson's disease and depression. A critical re-evaluation. , 1986, Brain : a journal of neurology.

[78]  J. Cummings,et al.  Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.

[79]  Organic Psychiatry , 1979, Neurology.

[80]  D. Benson,et al.  Dementia: A Clinical Approach , 1983 .

[81]  T. Bolwig,et al.  Crime in Huntington’s disease: a study of registered offences among patients, relatives, and controls , 1998, Journal of neurology, neurosurgery, and psychiatry.

[82]  J. Hollerman,et al.  Reward prediction in primate basal ganglia and frontal cortex , 1998, Neuropharmacology.

[83]  G. Paulson,et al.  Dementia in Parkinson's disease. , 1986, Archives of neurology.

[84]  J. Jankovic,et al.  Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[85]  O. Suchowersky,et al.  Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. , 1997, Archives of neurology.

[86]  S Arndt,et al.  Regional brain enlargement in autism: a magnetic resonance imaging study. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[87]  T. Robbins,et al.  Neurobehavioural mechanisms of reward and motivation , 1996, Current Opinion in Neurobiology.

[88]  G. Sawle,et al.  PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[89]  K. Marder,et al.  The frequency and associated risk factors for dementia in patients with Parkinson's disease. , 1995, Archives of neurology.

[90]  H. Mayberg,et al.  A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[91]  P. Strick,et al.  Basal-ganglia 'projections' to the prefrontal cortex of the primate. , 2002, Cerebral cortex.

[92]  Mary M. Robertson,et al.  Annotation: Gilles de la Tourette syndrome--an update. , 1994, Journal of child psychology and psychiatry, and allied disciplines.

[93]  H. Singer,et al.  Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome , 1991, Annals of neurology.

[94]  A. Parent,et al.  Carpenter's Human Neuroanatomy , 1996 .

[95]  R. Coursey,et al.  Lateral preference and neuropsychological correlates of schizotypy , 1992, Psychiatry Research.

[96]  A. Green,et al.  Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. , 1998, The Journal of nervous and mental disease.

[97]  R. Coppola,et al.  Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding , 1996, Science.

[98]  P. Strick,et al.  New concepts about the organization of basal ganglia output. , 1997, Advances in neurology.

[99]  M. Robertson,et al.  Tourette syndrome, associated conditions and the complexities of treatment. , 2000, Brain : a journal of neurology.

[100]  J. Stevens,et al.  Kindling of the mesolimbic dopamine system , 1978, Neurology.

[101]  C. Tanner Epidemiology of Parkinson’s Disease , 1992, Neurologic Clinics.

[102]  A. J. Kumar,et al.  Cortical magnetic resonance imaging changes in elderly inpatients with major depression. , 1991, The American journal of psychiatry.

[103]  J. Joyce,et al.  D3 Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics , 1999, Annals of the New York Academy of Sciences.

[104]  Johannes Lehtonen,et al.  Striatal dopamine transporter density in major depression , 1999, Psychopharmacology.

[105]  J. Cummings,et al.  Depression in patients with Parkinson's disease , 1999, International journal of geriatric psychiatry.

[106]  F. Goodwin Psychiatric side effects of levodopa in man. , 1971, JAMA.

[107]  R Kikinis,et al.  Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. , 1997, Archives of neurology.

[108]  J. Bradshaw,et al.  Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? , 1999, Clinical psychology review.

[109]  E. Wolters,et al.  Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease , 1996, Neurology.

[110]  J. Joyce,et al.  Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and islands of Calleja. , 1999, The Journal of pharmacology and experimental therapeutics.

[111]  G. Hynd,et al.  Attention Deficit- Hyperactivity Disorder and Asymmetry of the Caudate Nucleus , 1993, Journal of child neurology.

[112]  D. Chamberlin The American Psychiatric Press Textbook of Geriatric Neuropsychiatry , 1996 .

[113]  G. Koob The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction , 1999, Annals of the New York Academy of Sciences.

[114]  JaneR . Taylor,et al.  Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli , 1999, Psychopharmacology.

[115]  W. Drevets Prefrontal Cortical‐Amygdalar Metabolism in Major Depression , 1999, Annals of the New York Academy of Sciences.

[116]  M. Akil,et al.  Psychiatric and behavioral abnormalities in Wilson's disease. , 1995, Advances in neurology.

[117]  Takashi Hanakawa,et al.  Cognitive Slowing in Parkinson's Disease: A Behavioral Evaluation Independent of Motor Slowing , 2002, The Journal of Neuroscience.

[118]  P. Strick,et al.  Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. , 1994, Science.

[119]  D H Geschwind,et al.  Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). , 1999, American journal of human genetics.

[120]  I. Hickie,et al.  Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression , 1995, Biological Psychiatry.

[121]  A. Lieberman Managing the neuropsychiatric symptoms of Parkinson's disease , 1998, Neurology.

[122]  Manzar Ashtari,et al.  Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine , 1995, The Lancet.

[123]  Daniel R. Weinberger,et al.  Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground , 1995, Schizophrenia Research.

[124]  Donald M. Hilty The American Psychiatric Press Textbook of Geriatric Neuropsychiatry , 1995 .

[125]  Jane S. Paulsen,et al.  Neuropsychiatric aspects of Huntington's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[126]  J S Fowler,et al.  Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. , 2000, Cerebral cortex.

[127]  J. Saint-Cyr,et al.  Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease , 1998, Neurology.

[128]  A. Deutch Identification of the neural systems subserving the actions of clozapine: clues from immediate-early gene expression. , 1994, The Journal of clinical psychiatry.

[129]  B. Bogerts,et al.  Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[130]  M. Robertson,et al.  Sex of parent transmission effect in Tourette's syndrome , 1997, Neurology.

[131]  A. Parent,et al.  The current model of basal ganglia organization under scrutiny , 1998, Movement disorders : official journal of the Movement Disorder Society.

[132]  A. Graybiel Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.

[133]  M. Kunik,et al.  The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[134]  G. Celesia,et al.  Psychosis and other psychiatric manifestations of levodopa therapy. , 1970, Archives of neurology.

[135]  J. Cummings,et al.  Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[136]  A. Lees,et al.  The clinical features of 67 patients with clinically definite Steele-Richardson-Olszewski syndrome. , 1992, Behavioural neurology.

[137]  W. Honer,et al.  An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. , 2001, The American journal of psychiatry.

[138]  J. Jankovic,et al.  Tourettism and dystonia after subcortical stroke , 2002, Movement disorders : official journal of the Movement Disorder Society.

[139]  T. Dening,et al.  Wilson's disease. Psychiatric symptoms in 195 cases. , 1989, Archives of general psychiatry.

[140]  D. Mash,et al.  Dopamine transport function is elevated in cocaine users , 2002, Journal of neurochemistry.

[141]  K. Marder,et al.  Antecedent clinical features associated with dementia in Parkinson's disease , 1993, Neurology.

[142]  R. Mindham Psychiatric symptoms in Parkinsonism. , 1970, Journal of neurology, neurosurgery, and psychiatry.

[143]  A. E. Taylor,et al.  The Neuropsychology of Parkinsons-Disease , 1995, Brain and Cognition.

[144]  P. Renshaw,et al.  Major depression and the basal ganglia. , 1997, The Psychiatric clinics of North America.

[145]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[146]  T. Aziz,et al.  Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. , 1998, Brain : a journal of neurology.

[147]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.